AOC1	Amine Oxidase 1;
ATOX1	Antioxidant 1 Copper Chaperone;
ATP7A	ATPase copper transporting alpha;
CCS	Copper Chaperone for Superoxide Dismutase;
COMMD1	Copper Metabolism Domain Containing 1;
COX11	Cytochrome c Oxidase Copper Chaperone 11;
COX17	Cytochrome c Oxidase Copper Chaperone 17;
CP	ceruloplasmin;
CRC	Colorectal Cancer;
CTR1	Copper Transport protein 1;
CTR2	Copper Transport protein 2;
CXCL12	Chemokine C-X-C Motif Ligand 12;
CXCR4	Chemokine C-X-C Motif Receptor 4;
DMT1	Divalent Metal Transporter 1;
FPN1	Ferroportin 1;
GPX1	Glutathione Peroxidase 1;
DSF	Disulfiram;
ECM	Extracellular Matrix;
EMT	epithelial–mesenchymal transition;
ER	Endoplasmic Reticulum;
ES	Elesclomol;
ETC-derived	Electron Transport Chain-derived);
GSH	Glutathione;
HEPH	hephaestin;
HIF-1α	Hypoxia-Inducible Factor 1α;
HMGB1	High Mobility Group Box 1;
INOS	Inducible Nitric Oxide Synthase;
LOXL4	Lysyl Oxidase Homolog 4;
MD	Menkes Disease;
MTs	Metallothioneins;
MCFs	Multi-copper ferroxidases;
NF-κB	Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells;
PAM	Peptidylglycine α-Amidating Monooxygenase;
PAMPs	Pathogen-Associated Molecular Patterns;
PD-L1	Programmed cell death ligand 1;
ROS	Reactive Oxygen Species;
SCFAs	Short-Chain Fatty Acids;
SCO1	Synthesis of Cytochrome C Oxidase 1;
SCO2	Synthesis of Cytochrome C Oxidase 2;
SLC11A2	Solute Carrier Family 11 Member 2;
SLC31A1	Solute Carrier Family 31 Member 1;
SLC31A2	Solute Carrier Family 31 Member 2;
SOD1	Cu/Zn-Superoxide Dismutase 1;
STEAP	Six-Transmembrane Epithelial Antigen of the Prostate;
STEAP4	Six-Transmembrane Epithelial Antigen of the Prostate 4;
TCA	Tricarboxylic Acid;
TGN	Trans-Golgi Network;
TLR4	Toll-Like Receptor 4;
TPEN	N,N,N′,N′-tetrakis-[2-pyridylmethyl]-ethylenediamine;
TTM	Tetrathiomolybdate;
VEGF	Vascular Endothelial Growth Factor;
XIAP	X-linked Inhibitor of Apoptosis Protein;
5-FU	5-Fluorouracil,
PTT	photothermal therapy,
PDT	photodynamic therapy.